Cencora’s FormularyDecisions has introduced a groundbreaking resource tailored for healthcare payers navigating the evolving landscape of cell and gene therapy (CGT) products. This initiative aims to centralize information on approved therapies and those in development, aiding payers in making informed coverage decisions.

FormularyDecisions, a secure online platform, serves as a hub for evidence-based resources, fostering collaboration between biopharma companies and payers. With this new CGT resource, registered healthcare payers gain access to comprehensive data on the CGT landscape, including clinical evidence, health economic information, launch status, and FDA designations.

“Cell and gene therapies present significant promise but pose challenges for payers, particularly regarding cost and limited durability data,” explained Melissa McCart, Vice President of Commercialization Strategy & Access Solutions at Cencora. “FormularyDecisions equips payers with critical insights to evaluate the value of CGT products and make coverage decisions accordingly.”

The Alliance for Regenerative Medicine reports nearly 2,000 CGT clinical trials worldwide, with up to 17 regulatory decisions expected in 2024 across the U.S. and Europe. To address this influx, FormularyDecisions streamlines information exchange and supports payer decision-making.

Lung-I Cheng, Vice President and Head of Cell & Gene Therapy Service Line at Cencora, emphasized the importance of early engagement with payers. “Initiating discussions early allows CGT developers to understand payer expectations and tailor evidence packages accordingly,” Cheng noted. “FormularyDecisions facilitates this dialogue, promoting effective communication of product value information.”

The launch of FormularyDecisions underscores Cencora’s commitment to advancing innovation and access in the CGT space. Alongside this initiative, Cencora recently unveiled a CGT Integration Hub, enhancing visibility and streamlining the path-to-care for providers and patients alike.

Cencora continues to support CGT developers at every stage of the product lifecycle, fostering collaboration across the healthcare ecosystem to drive progress and improve patient outcomes.